Publications by authors named "Miles D Chapman"

Claim this Profile
C
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.
Constance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, Chiara Zecca, Giancarlo Logroscino, Miles D Chapman

Alzheimers Dement· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
Constance Delaby, Charlotte E Teunissen, Kaj Blennow, Daniel Alcolea, Ivan Arisi, Miles D Chapman

Alzheimers Dement· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF biomarkers for dementia.
Ashvini Keshavan, Frankie O'Shea, Miles D Chapman, Melanie S Hart, Michael Pt Lunn

Pract Neurol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lumbar drains can affect CSF biomarker levels.
Claudia Louise Craven, Miles D Chapman, Linda D'Antona, Simon D Thompson, Neghat Lakdawala

J Clin Pathol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Ross W Paterson, Catherine F Slattery, Teresa Poole, Jennifer M Nicholas, Nadia K Magdalinou, Miles D Chapman

Alzheimers Res Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
Claudia L Craven, Irene Baudracco, Henrik Zetterberg, Michael P T Lunn, Miles D Chapman

Acta Neurochir (Wien)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Ross W Paterson, Jamie Toombs, Miles D Chapman, Jennifer M Nicholas, Amanda J Heslegrave

Alzheimers Dement (Amst)· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an important potential confound in CSF AD studies: aliquot volume.
Jamie Toombs, Ross W Paterson, Michael P Lunn, Jenifer M Nicholas, Nick C Fox, Miles D Chapman

Clin Chem Lab Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus.
Andrew Tarnaris, Ahmed K Toma, Emily Pullen, Miles D Chapman, Axel Petzold

Alzheimers Dement· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus.
Andrew Tarnaris, Ahmed K Toma, Miles D Chapman, Geoff Keir, Neil D Kitchen

J Neurosurg· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rostrocaudal dynamics of CSF biomarkers.
Andrew Tarnaris, Ahmed K Toma, Miles D Chapman, Axel Petzold, Geoff Keir

Neurochem Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting.
Miles D Chapman, Edward J Thompson, Paul M Candler, Russell C Dale, Andrew J Church

J Neuroimmunol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of antibody affinity for specific antigens in the differential diagnosis of inflammatory nervous system disorders.
Gavin Giovannoni, Miles D Chapman, Edward J Thompson

J Neuroimmunol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of high affinity antibodies on antigen-immunoblots.
Miles D Chapman, Geoffrey Keir, Axel Petzold, Edward J Thompson

J Immunol Methods· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for production of intrathecal immunoglobulin G against Acinetobacter or Pseudomonas in multiple sclerosis.
Miles D Chapman, Lucy E Hughes, Clyde D Wilson, Simon Namnyak, Edward J Thompson

Eur Neurol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?
Andrew J Church, Russell C Dale, Francisco Cardoso, Paul M Candler, Miles D Chapman

J Neuroimmunol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis